Coordinated induction of cyclooxygenase-2/ prostaglandin E₂ and hepatocyte growth factor by apoptotic cells prevents lung fibrosis

Medicine and Dentistry

• Pulmonary Fibrosis 100%
• Scatter Factor 100%
• Cyclooxygenase 2 100%
• Hepatocyte Growth Factor 100%
• Prostaglandin E2 100%
• Bleomycin 50%
• Lung 33%
• Upregulation 16%
• Anti-Inflammatory Drug 16%
• Antiapoptotic 16%
• Alveolar Macrophage 16%
• Bleomycin-Induced Pulmonary Fibrosis 16%
• Positive Feedback 16%
• Hydroxyproline 16%
• 5 (2,6 Dichlorobenzylsulfonyl) 3 [3,5 Dimethyl 4 [2 (1 Pyrrolidinylmethyl) 1 Pyrrolidinylcarbonyl] 1h Pyrrol 2 Ylmethylene] 1,3 Dihydro 2h Indol 2 One 16%
• N (2 Cyclohexyloxy 4 Nitrophenyl)methanesulfonamide 16%
• 6 Isopropoxy 9 Oxo 2 Xanthenecarboxylic Acid 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Hepatocyte Growth Factor 100%
• Lung Fibrosis 100%
• Scatter Factor 100%
• Cyclooxygenase 2 100%
• Prostaglandin E2 100%
• Bleomycin 50%
• Anti-Inflammatory Drug 16%
• Antiapoptotic 16%
• NS-398 16%
• Bleomycin-Induced Pulmonary Fibrosis 16%
• Hydroxyproline 16%
• 5 (2,6 Dichlorobenzylsulfonyl) 3 [3,5 Dimethyl 4 [2 (1 Pyrrolidinylmethyl) 1 Pyrrolidinylcarbonyl] 1h Pyrrol 2 Ylmethylene] 1,3 Dihydro 2h Indol 2 One 16%
• 6 Isopropoxy 9 Oxo 2 Xanthenecarboxylic Acid 16%